drugset

drugset / Trial / NCT04187339

Study of NGM395 in Adult Participants

NCT04187339 ↗

Phase 1 Completed 38 enrolled NGM Biopharmaceuticals, Inc

RandomizedSequentialQuadruple-blindTreatment

Summary

Study of NGM395 in adult participants.

Timeline

Start: 2020-02-13
Primary completion: 2020-10-20
Completion: 2021-04-22

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NGM395	Unknown	—	Subcutaneous

Indications